«上一篇/Previous Article|本期目录/Table of Contents|下一篇/Next Article»

《天津医科大学学报》[ISSN:1006-8147/CN:12-1259/R]

卷:

29卷

期数:

2023年01期

页码:

41-45

栏目:

基础医学

出版日期:

2023-01-20

文章信息/Info

Title:

Metformin inhibits the differentiation of C2C12 murine skeletal muscle cells by regulating MSTN

文章编号:

1006-8147(2023)01-0041-05

作者:

郭洋; 张露露; 牛文彦

（天津医科大学基础医学院免疫学系，天津300070）

Author(s):

GUO Yang; ZHANG Lu-lu; NIU Wen-yan

（Department of Immunology，School of Basic Medical Sciences，Tianjin Medical University，Tianjin 300070，China）

关键词:

二甲双胍; 骨骼肌; 分化; MSTN

Keywords:

Metformin; skeletal muscle; differentiation; MSTN

分类号:

R392.1

DOI:

-

文献标志码:

A

摘要:

目的：探讨二甲双胍对小鼠骨骼肌细胞C2C12分化的影响及其分子机制。方法：将小鼠骨骼肌C2C12细胞系分为对照组和二甲双胍（5 mmol/L）组，用含5%马血清分化培养基诱导C2C12细胞分化，观察肌管形成情况。qPCR检测肌球蛋白重链（MyHC）和肌肉生长抑制素（MSTN）mRNA水平。Western 印迹检测MyHC、Ⅰ型肌球蛋白重链（MyHCⅠ）、Ⅱa型肌球蛋白重链（MyHCⅡa）、Ⅱb型肌球蛋白重链（MyHCⅡb）、Ⅱx型肌球蛋白重链（MyHCⅡx）和MSTN蛋白表达。应用siRNA下调MSTN的表达，并将小鼠骨骼肌C2C12细胞系分为MSTN敲低阴性对照组（siNC组），MSTN敲低阴性对照+二甲双胍组（siNC+metformin组），MSTN敲低组（siMSTN组），MSTN敲低+二甲双胍组（siMSTN+metformin组），检测二甲双胍是否通过升高MSTN抑制C2C12细胞分化。结果：显微镜观察显示，与对照组相比，二甲双胍组肌管数量减少、肌管直径较小。qPCR结果显示，与对照组相比，二甲双胍组MyHC mRNA水平降低（t=29.47，P＜0.000 1），MSTN mRNA水平增加（t=14.14，P＜0.001）。Western印迹结果显示，与对照组相比，二甲双胍组MyHC蛋白水平降低（t=12.57，P＜0.001），MSTN蛋白水平升高（t=6.555，P＜0.01），MyHCⅠ、MyHCⅡa、MyHCⅡb和MyHCⅡx蛋白水平降低（t=9.288、6.140、8.348、14.75，均P＜0.01）。应用siRNA下调MSTN的表达，与siNC组相比，siNC+metformin组MyHC蛋白水平显著降低（P＜0.001），与siNC+metformin组相比，siMSTN+metformin组MyHC蛋白水平升高（F=12.44，P＜0.001）。结论：二甲双胍通过调控MSTN，抑制小鼠骨骼肌细胞C2C12分化。

Abstract:

Objective： To investigate the effect of metformin on differentiation of murine C2C12 skeletal muscle cells and its potential molecular mechanism. Methods：Murine skeletal muscle C2C12 cells were divided into control group and metformin（5 mmol/L） group. The differentiation medium containing 5% horse serum was used to induce the differentiation of C2C12 cells and the formation of myotubes was observed. The mRNA levels of myosin heavy chain（MyHC） and myostatin（MSTN） were detected by qPCR.The protein expression of MyHC I，MyHCⅡa，MyHC Ⅱb，MyHCⅡx and MSTN were detected by Western blotting. Murine skeletal muscle C2C12 cell lines were divided into MSTN knockdown negative control group（siNC group），MSTN knockdown negative control +metformin group（siNC+metformin group），MSTN knockdown group（siMSTN group），MSTN knockdown+metformin group（siMSTN+metformin group），and the expression of MSTN was down-regulated by siRNA to investigate whether metformin inhibited the differentiation of C2C12 cells by regulating MSTN. Results：Compared with the control group，the metformin group had less myotube number and diameter. The qPCR results showed that compared with the control group，the level of MyHC mRNA in metformin group decreased（t=29.47，P<0.000 1），while the level of MSTN mRNA increased（t=14.14，P<0.001）. Western blotting results showed that compared with the control group，the expression of MyHC protein in metformin group decreased（t=12.57，P<0.001），the expression of MSTN protein increased（t=6.555，P<0.01）. The protein expression of MyHC Ⅰ，MyHCⅡa，MyHCⅡb and MyHCⅡx decreased（t=9.288，6.140，8.348，14.75，all P<0.01）. The expression of MSTN was down-regulated by siRNA. Compared with siNC group，the expression of MyHC in siNC+metformin group was significantly decreased（P<0.001）. Compared with siNC+metformin group，the expression of MyHC protein in siMSTN+metformin group was increased（F=12.44，P<0.001）. Conclusion：Metformin inhibits the differentiation of murine C2C12 skeletal muscle cells by regulating MSTN.

参考文献/References:

[1] KAMEI Y，HATAZAWA Y，UCHITOMI R，et al. Regulation of skeletal muscle function by amino acids[J]. Nutrients，2020，12（1）：261.
[2] MERZ K E，THURMOND D C. Role of skeletal muscle in insulin resistance and glucose uptake[J]. Compr Physiol，2020，10（3）：785-809.
[3] WELCH A A，HAYHOE RPG，CAMERON D. The relationships between sarcopenic skeletal muscle loss during ageing and macronutrient metabolism，obesity and onset of diabetes[J]. Proc Nutr Soc，2020，79（1）：158-169.
[4] YIN L，LI N，JIA W，et al. Skeletal muscle atrophy：from mechanisms to treatments[J]. Pharmacol Res，2021，172：105807.
[5] MARTIN A，FREYSSENET D. Phenotypic features of cancer cachexia-related loss of skeletal muscle mass and function：lessons from human and animal studies[J]. J Cachexia Sarcopenia Muscle，2021， 12（2）：252-273.
[6] MORGAN J，PARTRIDGE T. Skeletal muscle in health and disease[J]. Dis Model Mech，2020，13（2）：dmm042192.
[7] MURGIA M，NOGARA L，BARALDO M，et al. Protein profile of fiber types in human skeletal muscle：a single-fiber proteomics study[J]. Skelet Muscle，2021，11（1）：24.
[8] BURKLY L C. Regulation of tissue responses：the TWEAK/Fn14 pathway and other TNF/TNFR superfamily members that activate non-canonical NFkappaB signaling[J]. Front Immunol，2015，6：92.
[9] GAO L，YANG M，WEI Z，et al. MSTN mutant promotes myogenic differentiation by increasing demethylase TET1 expression via the SMAD2/SMAD3 pathway[J]. Int J Biol Sci，2020，16（8）：1324-1334.
[10] FORETZ M，GUIGAS B，VIOLLET B. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus[J]. Nat Rev Endocrinol，2019，15（10）：569-589.
[11] FENG J，WANG X，YE X，et al. Mitochondria as an important target of metformin：the mechanism of action，toxic and side effects，and new therapeutic applications[J]. Pharmacol Res，2022，177：106114.
[12] HUNTER R W，HUGHEY C C，LANTIER L，et al. Metformin reduces liver glucose production by inhibition of fructose-1-6-bisphosphatase[J]. Nat Med，2018，24（9）：1395-1406.
[13] HAWLEY S A，ROSS F A，CHEVTZOFF C，et al. Use of cells expressing gamma subunit variants to identify diverse mechanisms of AMPK activation[J]. Cell Metab，2010，11（6）：554-565.
[14] ALSHAWI A，AGIUS L. Low metformin causes a more oxidized mitochondrial NADH/NAD redox state in hepatocytes and inhibits gluconeogenesis by a redox-independent mechanism[J]. J Biol Chem，2019，294（8）：2839-2853.
[15] WALTON R G，DUNGAN C M，LONG D E，et al. Metformin blunts muscle hypertrophy in response to progressive resistance exercise training in older adults：a randomized，double-blind，placebo-controlled，multicenter trial：the MASTERS trial[J]. Aging Cell，2019， 18（6）：e13039.
[16] LEENDERS M，VERDIJK L B，VAN DER HOEVEN L，et al. Patients with type 2 diabetes show a greater decline in muscle mass，muscle strength，and functional capacity with aging[J]. J Am Med Dir Assoc，2013，14（8）：585-592.
[17] PAVLIDOU T，ROSINA M，FUOCO C，et al. Regulation of myoblast differentiation by metabolic perturbations induced by metformin[J]. PLoS One，2017，12（8）：e0182475.
[18] CHEN X，GUO Y，JIA G，et al. Arginine promotes skeletal muscle fiber type transformation from fast-twitch to slow-twitch via Sirt1/AMPK pathway[J]. J Nutr Biochem，2018，61：155-162.
[19] DAMER A，EL MENIAWY S，MCPHERSON R，et al. Association of muscle fiber type with measures of obesity：a systematic review[J]. Obes Rev，2022，23（7）：e13444.
[20] AGUIRRE F，ABRIGO J，GONZALEZ F，et al. Protective effect of angiotensin 1-7 on sarcopenia induced by chronic liver disease in mice[J]. Int J Mol Sci，2020，21（11）：3891.
[21] ESPOSITO P，PICCIOTTO D，BATTAGLIA Y，et al. Myostatin：basic biology to clinical application[J].Adv Clin Chem，2022，106：181-234.
[22] YANG W，CHEN Y，ZHANG Y，et al. Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression[J].Cancer Res，2006，66（3）：1320-1326.
[23] BATAILLE S，CHAUVEAU P，FOUQUE D，et al. Myostatin and muscle atrophy during chronic kidney disease[J]. Nephrol Dial Transplant，2021，36（11）：1986-1993.

相似文献/References:

[1]李 青,郭 刚,Bilan Philip,等.电刺激促进大鼠骨骼肌细胞GLUT4转位并激活Akt信号通路[J].天津医科大学学报,2014,20(02):102.
　LI Qing,GUO Gang,Bilan Philip,et al.Electric pulse stimulation-induced GLUT4 translocation and activated Akt signaling pathway in L6-GLUT4myc-AS160 myotubes[J].Journal of Tianjin Medical University,2014,20(01):102.
[2]刘 倩,胡 芳,牛文彦.AMPK腺病毒载体在小鼠骨骼肌中的表达和作用[J].天津医科大学学报,2016,22(01):1.
　LIU Qian,HU Fang,NIU Wen-yan.Effect and expression of AMPK adenovirus on mouse skeletal muscle[J].Journal of Tianjin Medical University,2016,22(01):1.
[3]刘 豫,薄志强,张志宏.糖尿病及二甲双胍对上尿路肿瘤术后复发的影响[J].天津医科大学学报,2017,23(01):53.
　LIU Yu,BO Zhi-qiang,ZHANG Zhi-hong.Effect of diabetes mellitus and metformin on intravesical recurrence after radical operation in patients with upper urinary tract urothelial carcinoma[J].Journal of Tianjin Medical University,2017,23(01):53.
[4]吕晓婷,洪宇桁,牛文彦.短链脂肪酸对C2C12小鼠骨骼肌细胞AMPK的作用研究[J].天津医科大学学报,2019,25(01):1.
　LV Xiao-ting,HONG Yu-heng,NIU Wen-yan.Effect of short-chain fatty acids on AMPK in mouse C2C12 skeletal muscle cells[J].Journal of Tianjin Medical University,2019,25(01):1.
[5]蒋腾,朱仲玲综 述,阎昭审 校.二甲双胍抗肿瘤作用的研究进展[J].天津医科大学学报,2020,26(06):577.
[6]齐睿,牛文彦.双氢睾酮逆转棕榈酸诱导的小鼠骨骼肌细胞胰岛素抵抗及其机制[J].天津医科大学学报,2022,28(02):140.
　QI Rui,NIU Wen-yan.Palmitic acid-induced insulin resistance in mouse skeletal muscle cells reversed by dihydrotestosterone and its mechanism[J].Journal of Tianjin Medical University,2022,28(01):140.
[7]岳莹莹,穆红,牛文彦.Axin1调节骨骼肌GLUT4蛋白表达的作用研究[J].天津医科大学学报,2023,29(01):36.
　YUE Ying-ying,MU Hong,NIU Wen-yan.Study the effect of Axin1 on regulating GLUT4 protein in skeletal muscle[J].Journal of Tianjin Medical University,2023,29(01):36.
[8]张露露,郭洋,王新莉,等.组蛋白去乙酰化酶抑制剂Chidamide抑制C2C12骨骼肌细胞分化及其机制[J].天津医科大学学报,2023,29(02):142.
　ZHANG Lu-lu,GUO Yang,WANG Xin-li,et al.The inhibitive effect of histone deacetylase inhibitor Chidamide on the differentiation of C2C12 skeletal muscle cells and its mechanism[J].Journal of Tianjin Medical University,2023,29(01):142.
[9]倪钰鸽,盛 菲,牛文彦.环氧化酶2抑制剂parecoxib对C2C12骨骼肌细胞分化的影响及机制研究[J].天津医科大学学报,2024,30(02):138.[doi:10.20135/j.issn.1006-8147.2024.02.0138]
　NI Yuge,SHENG Fei,NIU Wenyan.Study of effect and mechanism of cyclooxygenase-2 inhibitor parecoxib on the differentiation of C2C12 skeletal muscle cells[J].Journal of Tianjin Medical University,2024,30(01):138.[doi:10.20135/j.issn.1006-8147.2024.02.0138]

备注/Memo

备注/Memo:

基金项目: 国家自然科学基金面上项目（81870547）；天津市教委科研计划项目（2019ZD028）
作者简介:郭洋（1998-），女，硕士在读，研究方向：医学技术（检验方向）；通信作者：牛文彦，E-mail：wniu@tmu.edu.cn。

常用功能

更新日期/Last Update: 2023-02-01